• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国云南省 COPD 患者住院费用的影响因素:路径分析。

Factors contributing to hospitalization expenditures for patients with COPD in Yunnan Province, China: a path analysis.

机构信息

Institute of Health Studies, School of Public Health, Kunming Medical University, 1168 West Chunrong Road, Yuhua Street, Chenggong District, Kunming, Yunnan, 650500, China.

Department of Pulmonary and Critical Care Medicine, the First People's Hospital of Yunnan Province, 157 Jinbi Road, Xishan District, Kunming, Yunnan, 650032, China.

出版信息

BMC Health Serv Res. 2024 Nov 28;24(1):1496. doi: 10.1186/s12913-024-11874-4.

DOI:10.1186/s12913-024-11874-4
PMID:39609664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11603990/
Abstract

OBJECTIVE

To understand the hospitalization expenditures and the composition of hospitalized patients with chronic obstructive pulmonary disease (COPD) in Yunnan Province from 2016 to 2022 and to identify the factors that influence them. The study aims to provide evidence-based information to health administration, hospitals, health insurance offices, and other related departments to help them formulate relevant policies.

METHODS

This study analyzed data from 728,980 COPD patients in Yunnan Province between 2016 and 2022. This study described trends in hospitalization expenditures and their components over a 7-year period. Path analysis was used to investigate the factors that affect hospitalization expenditures.

RESULTS

The average hospitalization expenditures for 2016-2022 were 7828 CNY. The total hospitalization expenditures were continuously increasing, from 828 million CNY to 967 million CNY, which is a 16.84% increase. However, the average expenditure per hospitalization decreased from 9185 CNY to 7261 CNY, which is a decrease of 20.95%. The main components of hospitalization expenditures were diagnostic fees, medication fees, and comprehensive medical service fees. The proportion of medication fees is decreasing, while the proportion of diagnostic fees and comprehensive medical services fees are increasing. The results of the path analysis indicate that age, gender, ethnicity, hospital level, admission route, medical payment method, COPD with acute lower respiratory tract infection, non-acute exacerbation of COPD, rehabilitation treatment experience, and comorbidity have both direct and indirect effects on hospitalization expenditures through length of stay (LOS). Additionally, marital status indirectly affects hospitalization expenditures through LOS.

CONCLUSION

Shortening the average LOS is crucial for hospitals to improve efficiency and reduce unnecessary expenses for patients. To achieve this, it is necessary to actively implement clinical pathway management and establish a standardized diagnosis and treatment system.

摘要

目的

了解云南省慢性阻塞性肺疾病(COPD)患者住院费用及构成,分析其影响因素,为卫生行政部门、医院、医保经办机构等相关部门制定政策提供依据。

方法

本研究分析了云南省 2016 年至 2022 年 728980 例 COPD 患者住院费用数据,描述了 7 年住院费用及构成的变化趋势,采用路径分析方法探讨影响住院费用的因素。

结果

2016-2022 年云南省 COPD 患者平均住院费用为 7828 元,总住院费用呈持续增长趋势,由 8.28 亿元增加至 9.67 亿元,增长 16.84%;但次均住院费用由 9185 元降至 7261 元,下降 20.95%。住院费用主要构成为检查费、药品费和治疗费,其中药品费占比逐渐下降,检查费和治疗费占比逐渐上升。路径分析结果显示,年龄、性别、民族、医院级别、入院途径、支付方式、合并 COPD 急性下呼吸道感染、非急性加重期 COPD、康复治疗经历、合并症等因素通过住院天数(LOS)对住院费用产生直接和间接影响,婚姻状况通过 LOS 对住院费用产生间接影响。

结论

缩短平均 LOS 对医院提高效率、减少患者不必要费用支出具有重要意义,应积极推行临床路径管理,建立规范的诊疗体系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/978c/11603990/6de6b79bf98e/12913_2024_11874_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/978c/11603990/df3bbc779afb/12913_2024_11874_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/978c/11603990/6de6b79bf98e/12913_2024_11874_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/978c/11603990/df3bbc779afb/12913_2024_11874_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/978c/11603990/6de6b79bf98e/12913_2024_11874_Fig2_HTML.jpg

相似文献

1
Factors contributing to hospitalization expenditures for patients with COPD in Yunnan Province, China: a path analysis.中国云南省 COPD 患者住院费用的影响因素:路径分析。
BMC Health Serv Res. 2024 Nov 28;24(1):1496. doi: 10.1186/s12913-024-11874-4.
2
Trends in Hospitalization Expenditures for Acute Exacerbations of COPD in Beijing from 2009 to 2017.2009 年至 2017 年北京 COPD 急性加重住院费用的变化趋势。
Int J Chron Obstruct Pulmon Dis. 2020 May 21;15:1165-1175. doi: 10.2147/COPD.S243595. eCollection 2020.
3
Impacts of the zero mark-up drug policy on hospitalization expenses of COPD inpatients in Sichuan province, western China: an interrupted time series analysis.中国西部四川省零加成药物政策对 COPD 住院患者住院费用的影响:一项中断时间序列分析。
BMC Health Serv Res. 2020 Jun 8;20(1):519. doi: 10.1186/s12913-020-05378-0.
4
Clinical factors and comorbidities affecting the cost of hospital-treated COPD.影响住院治疗慢性阻塞性肺疾病费用的临床因素及合并症。
Int J Chron Obstruct Pulmon Dis. 2016 Dec 2;11:3023-3030. doi: 10.2147/COPD.S120637. eCollection 2016.
5
Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data.中国慢性阻塞性肺疾病患者住院费用的影响因素:病历数据的回顾性分析
Int J Chron Obstruct Pulmon Dis. 2018 Oct 12;13:3349-3357. doi: 10.2147/COPD.S175143. eCollection 2018.
6
Analysis of hospitalization expenditures and influencing factors for inpatients with coronary heart disease in a tier-3 hospital in Xi'an, China: A retrospective study.中国西安某三级医院冠心病住院患者住院费用及影响因素分析:一项回顾性研究
Medicine (Baltimore). 2017 Dec;96(51):e9341. doi: 10.1097/MD.0000000000009341.
7
Analysis of hospitalization expenditures and influencing factors for inpatients with chronic bronchitis based on SHA2011 in a central Province of China.基于 SHA2011 分析中国某中部省份慢性支气管炎住院患者的住院费用及影响因素
Sci Rep. 2024 Oct 8;14(1):23495. doi: 10.1038/s41598-024-74521-2.
8
Hospitalization Costs and Financial Burden on Families with Children with Depression: A Cross-Section Study in Shandong Province, China.住院费用及中国山东省抑郁症患儿家庭经济负担:一项横断面研究
Int J Environ Res Public Health. 2019 Sep 20;16(19):3526. doi: 10.3390/ijerph16193526.
9
Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.医疗保险优势人群中慢性阻塞性肺疾病和哮喘并存的直接成本经济负担。
J Manag Care Pharm. 2008 Mar;14(2):176-85. doi: 10.18553/jmcp.2008.14.2.176.
10
Hospitalization costs of COPD cases and its associated factors: an observational study at two large public tertiary hospitals in Henan Province, China.COPD 病例的住院费用及其相关因素:中国河南省两家大型公立三级医院的观察性研究。
BMC Geriatr. 2023 Jul 25;23(1):457. doi: 10.1186/s12877-023-04087-7.

本文引用的文献

1
Hospitalization costs of COPD cases and its associated factors: an observational study at two large public tertiary hospitals in Henan Province, China.COPD 病例的住院费用及其相关因素:中国河南省两家大型公立三级医院的观察性研究。
BMC Geriatr. 2023 Jul 25;23(1):457. doi: 10.1186/s12877-023-04087-7.
2
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.慢性阻塞性肺疾病全球倡议组织2023年报告:《慢性阻塞性肺疾病全球倡议》执行摘要
Am J Respir Crit Care Med. 2023 Apr 1;207(7):819-837. doi: 10.1164/rccm.202301-0106PP.
3
The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019.
中国及各省 COPD 负担:来自 2019 年全球疾病负担研究的发现。
Front Public Health. 2022 Jun 3;10:859499. doi: 10.3389/fpubh.2022.859499. eCollection 2022.
4
Systematic Review of the Effect of a Zero-Markup Policy for Essential Drugs on Healthcare Costs and Utilization in China, 2015-2021.2015 - 2021年中国基本药物零加成政策对医疗成本和利用影响的系统评价
Front Med (Lausanne). 2021 Jul 22;8:618046. doi: 10.3389/fmed.2021.618046. eCollection 2021.
5
Association between Initiation of Pulmonary Rehabilitation and Rehospitalizations in Patients Hospitalized with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病住院患者启动肺康复与再住院的相关性。
Am J Respir Crit Care Med. 2021 Nov 1;204(9):1015-1023. doi: 10.1164/rccm.202012-4389OC.
6
Pneumonia Is Associated with Increased Mortality in Hospitalized COPD Patients: A Systematic Review and Meta-Analysis.肺炎与住院 COPD 患者死亡率升高相关:系统评价和荟萃分析。
Respiration. 2021;100(1):64-76. doi: 10.1159/000510615. Epub 2021 Jan 15.
7
Projecting Long-term Health and Economic Burden of COPD in the United States.预估美国慢性阻塞性肺疾病的长期健康和经济负担。
Chest. 2021 Apr;159(4):1400-1410. doi: 10.1016/j.chest.2020.09.255. Epub 2020 Oct 2.
8
The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature.慢性阻塞性肺疾病(COPD)在美国、欧洲和亚洲的经济负担:文献系统综述的结果。
Expert Rev Pharmacoecon Outcomes Res. 2020 Dec;20(6):661-672. doi: 10.1080/14737167.2020.1678385. Epub 2019 Oct 18.
9
The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature.欧洲慢性阻塞性肺疾病(COPD)的经济负担:文献系统评价的结果。
Eur J Health Econ. 2020 Mar;21(2):181-194. doi: 10.1007/s10198-019-01119-1. Epub 2019 Sep 28.
10
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.全球慢性阻塞性肺疾病诊断、管理和预防策略:GOLD 科学委员会报告 2019.
Eur Respir J. 2019 May 18;53(5). doi: 10.1183/13993003.00164-2019. Print 2019 May.